Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03074903 · ClinicalTrials.gov registry record
Does Skyla Insertion Timing Impact Bleeding?
A clinical trial of Vaginal Bleeding, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 132
- Enrollment target
- 3
- Study locations
NCT03074903 is a study of Vaginal Bleeding that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 132 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT03074903, a study of Vaginal Bleeding, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
- 3
- Study locations
Study Summary
Women presenting for contraception will be offered the IUS Skyla and study participation. Daily bleeding will be collected for a total of 90 days and correlated with insertion timing and baseline endometrial thickness.
Conditions Studied
Interventions
- DEVICE Intrauterine system
Study Locations (3)
New Jersey
- Planned Parenthood - Morristown
- NJFPC - Newark
- SHS - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2016-04-16 |
| Est. Completion | 2017-07-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03074903
The ClinicalTrials.gov registry entry for NCT03074903 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vaginal Bleeding appearing as the primary indexed condition, and to 1 intervention - of which Intrauterine system is the first listed.
NCT03074903 reports 3 study locations spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT03074903 about?
NCT03074903 is a clinical study titled "Does Skyla Insertion Timing Impact Bleeding?". Women presenting for contraception will be offered the IUS Skyla and study participation. Daily bleeding will be collected for a total of 90 days and correlated with insertion timing and baseline endometrial thickness.
What is the current status of trial NCT03074903?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2016-04-16. Estimated completion is 2017-07-28.
What conditions does trial NCT03074903 study?
This clinical trial studies the following conditions: Vaginal Bleeding.
What interventions are being tested in trial NCT03074903?
The interventions under investigation include: Intrauterine system (DEVICE).
Who is sponsoring clinical trial NCT03074903?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03074903 being conducted?
This trial has 3 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaginal Bleeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.